Evaluation of activity and phenotype of α1-antitrypsin in a civil population with respiratory complications following exposure to sulfur mustard 20 years ago

Biomarkers

Volumn 15, Issue 1, 2010, Pages 47-51

  Shohrati, Majid ^a   Shamspour, Navvab ^b   Babaei, Fatemeh ^c   Harandi, Ali Amini ^a   Mohsenifar, Afshin ^c   Aslani, Jafar ^a   Ghanei, Mostafa ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PAYAME NOOR UNIVERSITY   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

1 antitrypsin; Activity; Phenotype; Sulfur mustard

Indexed keywords

ALPHA 1 ANTITRYPSIN; MUSTARD GAS;

ADULT; ARTICLE; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HEMOPTYSIS; HUMAN; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN ELECTROPHORESIS; RESPIRATORY TRACT DISEASE; SPUTUM;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; CASE-CONTROL STUDIES; CHEMICAL WARFARE AGENTS; FEMALE; HUMANS; IRAN; ISOELECTRIC FOCUSING; MALE; MIDDLE AGED; MUSTARD GAS; PHENOTYPE; RESPIRATION DISORDERS;

EID: 75749109726     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903268318     Document Type: Article

References (32)

1. Atkins K, Lodhi I, Hurley L, Hinshaw D. (2000). N-acetylcysteine and endothelial cell injury by sulfur mustard. J Appl Toxicol 20 (Suppl. 1):S125-8.
2. Brantly M, Nukiwa T, Crystal R. (1988). Molecular basis of α1-antitrypsin deficiency. Am J Med 84:13-31.
3. Carp H, Miller F, Hoidal J, Janoff A. (1982). Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci USA 79:2041-2045
4. Carrell R, Jeppsson J, Laurell C, Brennan S, Owen M, Vaughan L, Boswell DR. (1982). Structure and variation of human α1-antitrypsin. Nature 298:329-334
5. Crystal R. (1989). The alpha 1-antitrypsin gene and its deficiency states. Trends Genet 5:411-417
6. Crystal R. (1990). α1-Antitrypsin deficiency emphysema and liver disease. Genetic basis and strategies of therapy. J Clin Invest 85:1343-1352
7. DeMeo D, Silverman E. (2004). Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 59: 259-264
8. de Serres F. (2002). Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 122:1818-1829
9. Fazlollahi M, Aghamohammadi A, Hosseini R, Lotfi A, Khoshdel A, Farhoudi A, Movahedi M, Gharagozlou M, Mozaffari H, Zandieh F, Mansouri M, Ghaffari J, Rezaei N. (2006). Study of alpha1-antitrypsin phenotypes frequencies in patients with primary antibody deficiency. Iranian J Allergy Asthma Immunol 5:69-74.
10. Freeman B, Transwell A. (1985). Biochemical and cellular aspects of pulmonary oxygen toxicity. Adv Free Radic Biol Med 1:133-164
11. Gedde-Dahl TJ, Frants R, Olaisen B, Eriksson A, van Loghem E, Lamm L. (1981). The Gm-Pi linkage heterogeneity in view of Pi M subtypes. Ann Hum Genet 45:143-153
12. Gelfand E, Cox D, Lin M, Dosch H. (1979). Severe combined immunedeficiency disease in patient with alpha 1-antitrypsin deficiency. Lancet 2:202. (Pubitemid 9222183)
13. Ghanei M, Harabdi AA. (2005). Long term consequences from exposure to sulfur mustard: a review. Inhalat Toxicol 19:51-56
14. Ghanei M, Shohrati M, Harandi A, Eshraghi M, Aslani J, Alaeddini F, Manzoori H. (2007). Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. Inhalat Toxicol 19:889-894
15. Jeppsson J, Franzen B. (1982). Typing of genetic variants of alpha 1-antitrypsin by electrofocusing. Clin Chem 28:219-225
16. Lomas D, Belorgey D, Mallya M, Onda M, Kinghorn K, Sharp L, Phillips RL, Page R, Crowther DC, Miranda E. (2004). Polymerisation underlies alpha1-antitrypsin deficiency dementia and other serpinopathies. Frontiers Biosci 9:2873-2891
17. Miravitlles M, de Gracia J, Rodrigo M, Cruz M, Vendrell M, Vidal R, Morell F. (1999). Specific antibody response against the 23-valent pneumococcal vaccine in patients with alpha(1)-antitrypsin deficiency with and without bronchiectasis. Chest 116:946-952
18. Morse J, Lebowitz M, Knudson R, Burrows B. (1977). Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N Engl J Med 296:1190-1194
19. O'Byrne P, Postma D. (1999). The many faces of airway inflammation: asthma and chronic obstructive pulmonary disease. Am J Resp Crit Care Med 159:S41-S63.
20. Ostergaard P. (1984). Alpha-1-antitrypsin levels and clinical symptoms in forty-eight children with selective IgA deficiency. Eur J Pediatr 142:276-278
21. Phung N, Harbeck R, Helbling-Muntges C. (1983). Familial hypogammaglobulinemia. Genetic linkage with alpha 1-antitrypsin deficiency. Arch Intern Med 143:575-577
22. Phung N, Kubo R, Spector S. (1982). Alpha 1-antitrypsin deficiency and common variable hypogammaglobulinemia in a patient with asthma. Chest 81:112-115
23. Rappeneau S, Baeza-Squiban A. Marano F, Calvet J. (2000). Efficient protection of human bronchial epithelial cells against sulfur and nitrogen mustard cytotoxicity using drug combinations. Toxicol Sci 58:153-160
24. Riley D, Kerr J. (1985). Oxidant injury of the extracellular matrix: potential role in the pathogenesis of pulmonary emphysema. Lung 163:1-13.
25. Sansom M, Ferry B, Sherrell Z, Chapel H. (2002). A preliminary assessment of alpha-1 antitrypsin S and Z deficiency allele frequencies in common variable immunodeficiency patients with and without bronchiectasis. Clin Exp Immunol 130:489-494
26. Sharp H, Bridges R, Krivit W, Freier E. (1969). Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 73:934-939
27. Shohrati M, Aslani J, Eshraghi M, Alaedini F, Ghanei M. (2008). Therapeutic effects of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test. Resp Med 102:443-448
28. Shohrati M, Ghanei M, Shamspour N. (2007a). Oxidative stress in lung injuries due to sulfur mustard. 44th Congress of the European Societies of Toxicology, Amsterdam Netherlands. C43.
29. Shohrati M, Peyman M, Peyman A, Davoudi M, Ghanei M. (2007b). Cutaneous and ocular late complications of sulfur mustard in Iranian veterans. Cutan Ocul Toxicol 26:73-81.
30. Southorn P, Powis G. (1988). Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc 63:390-408. (Pubitemid 18120781)
31. Stockley R. (1999). Neutrophils and protease/antiprotease imbalance. Am J Resp Crit Care Med 160:S49-S52.
32. Taggart C, Cervantes-Laurean D, Kim G, McElvaney N, Wehr N, Moss J, Levine RL. (2000). Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem 275:27258-27265